ISPR — Ispire Technology Inc.

Summary of Ispire Technology Inc. Q2 2026 Earnings Call

1. Key Financial Results and Metrics:

• Total Revenue: $20.3 million, down from $41.8 million in Q2 2025.
• Gross Profit: $3.5 million, a decline from $7.7 million; gross margin decreased to 17.1% from 18.5%.
• Net Loss: Reduced to $6.6 million from $8 million in Q2 2025; for the six months ending 12/31/2025, net loss decreased by $3.7 million year-over-year.
• Accounts Receivable: Improved to $37.9 million from $47 million at the end of fiscal 2025; cash collected versus revenue was 116% in 2025 compared to 67% in 2024.
• Operating Expenses: Reduced to $10.3 million from $15.1 million in Q2 2025; operating cash burn limited to $1 million from April 2025 to year-end.

2. Strategic Updates and Business Highlights:

• Shifted focus from lower-value cannabis customers to higher-quality nicotine sector clients.
• Progress on the iTech joint venture and Gmesh technology, with increased traction for age-gating technology in the U.S. market.
• The Malaysian facility build-out is on track, expected to increase production capacity significantly.
• Anticipation of a significant development deal related to age-gating technology with a leading global nicotine company.

3. Forward Guidance and Outlook:

• Management expects continued improvement in financial metrics, including cash flow and reduced net loss, as the company capitalizes on its strategic pivot.
• Anticipation of top-line growth and consistent cash flow in future quarters, with optimism surrounding the potential for FDA approval of flavored products using age-gating technology.

4. Bad News, Challenges, or Points of Concern:

• Revenue decline due to the strategic shift away from lower-value clients, which may impact short-term performance.
• International headwinds in the nicotine sector, particularly from Chinese manufacturers affecting e-cigarette volumes.
• The illicit market for e-cigarettes remains a significant challenge, with enforcement efforts not yet making a substantial impact.

5. Notable Q&A Insights:

• Retailers, including Walgreens, are showing increased demand for flavored e-cigarettes, and regulatory clarity could lead to expanded shelf space.
• The iQTEC partnership with Charlie's is expected to produce 2-3 million chips monthly, with potential growth to 10 million; interest from other brands in age-gating technology is rising.
• Concerns regarding the surge in Chinese imports before new VAT regulations take effect, with ongoing challenges in combating the illicit market.
• Management indicated that the upcoming deal could have a greater strategic and financial impact than previous partnerships.

Overall, Ispire Technology Inc. is navigating a challenging transition period, focusing on quality over quantity in its customer base while positioning itself for future growth in the nicotine sector through innovative technology and strategic partnerships.